Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04038567 · ClinicalTrials.gov registry record · NA
Optimizing a Mobile Mindfulness Intervention for ICU Survivors
A NA study of Cardiorespiratory Failure, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
- 3
- Study locations
NCT04038567: Completed NA study of Cardiorespiratory Failure, sponsored by Duke University.
NCT04038567 is a NA study of Cardiorespiratory Failure that has completed, run by Duke University. The registered enrollment target is 247 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04038567, a NA study of Cardiorespiratory Failure, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a factorial experimental trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is conceptualized as the Optimization Phase of a multiphase optimization strategy (MOST) framework. This will allow optimization of a mobile mindfulness intervention by comparing eight different iterations across domains including impact on symptoms, feasibility, acceptability, usability, scalability, and cost.
Primary Outcome
Absolute values, not change scores. Depression symptoms. Scores range from 0 (better) to 27 (worse)
Conditions Studied
Interventions
- BEHAVIORAL Mobile mindfulness-based training
Study Locations (3)
Colorado
- University of Colorado - Denver - Aurora
North Carolina
- Duke University Medical Center - Durham
Washington
- University of Washington - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2019-08-15 |
| Est. Completion | 2023-07-19 |
| Phase | NA |
What the finished NCT04038567 record still lists
NCT04038567 is an interventional study that assigns participants to a tested intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Cardiorespiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which Mobile mindfulness-based training is the first listed.
NCT04038567 reports a single indexed study location in Colorado, North Carolina, Washington.
Frequently Asked Questions
What is clinical trial NCT04038567 about?
NCT04038567 is a clinical study titled "Optimizing a Mobile Mindfulness Intervention for ICU Survivors". This is a factorial experimental trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is conceptualized as the Optimization Phase of a multiphase optimization strategy (MOST) framework. This will allow optimization of a mobile mindfulness intervent...
What is the current status of trial NCT04038567?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2019-08-15. Estimated completion is 2023-07-19.
What conditions does trial NCT04038567 study?
This clinical trial studies the following conditions: Cardiorespiratory Failure.
What interventions are being tested in trial NCT04038567?
The interventions under investigation include: Mobile mindfulness-based training (BEHAVIORAL).
Who is sponsoring clinical trial NCT04038567?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04038567 being conducted?
This trial has 3 study locations across Colorado, North Carolina, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04038567's enrollment target sits among peer trials
247 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI